KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Equity Ratio (2017 - 2025)

Historic Equity Ratio for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to 0.63.

  • Bionano Genomics' Equity Ratio rose 1261.24% to 0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year increase of 1261.24%. This contributed to the annual value of 0.46 for FY2024, which is 287.81% up from last year.
  • As of Q3 2025, Bionano Genomics' Equity Ratio stood at 0.63, which was up 1261.24% from 0.6 recorded in Q2 2025.
  • Bionano Genomics' Equity Ratio's 5-year high stood at 0.97 during Q2 2021, with a 5-year trough of 0.45 in Q4 2023.
  • Its 5-year average for Equity Ratio is 0.73, with a median of 0.79 in 2023.
  • Its Equity Ratio has fluctuated over the past 5 years, first surged by 52731.94% in 2021, then crashed by 4470.28% in 2023.
  • Over the past 5 years, Bionano Genomics' Equity Ratio (Quarter) stood at 0.89 in 2021, then fell by 9.28% to 0.81 in 2022, then tumbled by 44.7% to 0.45 in 2023, then increased by 2.88% to 0.46 in 2024, then skyrocketed by 36.52% to 0.63 in 2025.
  • Its last three reported values are 0.63 in Q3 2025, 0.6 for Q2 2025, and 0.61 during Q1 2025.